Best of the Week: Progress for transcatheter tricuspid devices | Cardiologists push back on FDA proposal

News You Need to Know Today

Saturday, July 2, 2022

This Week’s News

VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

Azeem Latib explains advances in transcatheter mitral and tricuspid valve therapies at TVT 2022. #TVT #TVT22 #TVT2022 #TMVR #TTVR

VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

New details on the pig heart transplant patient's death, from the doctors who treated him

Doctors involved with the historic procedure shared key details about their experience in the New England Journal of Medicine.

New details on the pig heart transplant patient's death, from the doctors who treated him

Doctors involved with the historic procedure shared key details about their experience in the New England Journal of Medicine.

VIDEO: TAVR's long-term impact on patient care

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care.

The Boston Scientific Acurate neo2,. Abbott Portico and the new Edwards Sapien X4 TAVR valves were hot topics of discussion at TCT 2022. #TVT #TVT22 #TVT2022

VIDEO: TAVR's long-term impact on patient care

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care. 

Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties.

The Society for Cardiovascular Angiography and Interventions (SCAI) has responded to the U.S. Food and Drug Administration’s (FDA’s) recommendation that all infants and young children who receive iodinated contrast media (ICM) undergo thyroid testing. The group pushed back against this proposal, emphasizing that implementation would have “far-reaching consequences.”

Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

Regulatory Roundup: FDA clears several new solutions, including Apple’s latest AFib offering

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions.

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Regulatory Roundup: FDA clears several new solutions, including Apple’s latest AFib offering

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions. 

Judge says Apple violated ECG patents, making U.S. import ban of Apple Watches a possibility

A judge from the U.S. International Trade Commission has said Apple violated multiple AliveCor patents. This story, however, is far from over.

Judge says Apple violated ECG patents, making U.S. import ban of Apple Watches a possibility

A judge from the U.S. International Trade Commission has said Apple violated multiple AliveCor patents. This story, however, is far from over.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

This Week’s News

Recent Newsletters